Small Cell Lung Cancer Prognosis After Recurrence

Almost 90 of lung cancers are this type.
Small cell lung cancer prognosis after recurrence. The progress that has been made in the treatment of small cell lung cancer has resulted from improved development of multi modality treatments and participation in clinical trials. For women the number is about 112 350 a year. The stage of a cancer describes how much cancer is in the body. Small cell lung cancer is a disease in which malignant cancer cells form in the tissues of the lung.
The lungs bring oxygen into the body when you breathe in and take out carbon dioxide when you breathe out. Also referred to as relapse lung cancer recurrence occurs far more often. Relative survival rates for non small cell lung cancer nsclc. The national cancer institute s database breaks down the cancers by how far the tumors.
Relapse of stage i small cell lung cancer ten or more years after the. After someone is diagnosed with small cell lung cancer sclc doctors will try to figure out if it has spread and if so how far. Lung cancer recurrence is generally defined as lung cancer that returns after treatment and following a period of more than three months of remission in which there is no evidence of the disease. This process is called staging.
It can cause symptoms ranging from fatigue to coughing up blood and is more aggressive than the more common non small cell lung cancer nsclc smoking is the leading cause of sclc and a biopsy is needed to confirm a diagnosis while it may respond to radiation and chemotherapy initially sclc can spread. Small cell lung cancer sclc accounts for approximately 15 of all lung cancers. Each lung has sections called lobes the left lung has two lobes. It helps determine how serious the cancer is and how best to treat it.
The lungs are a pair of cone shaped breathing organs that are found in the chest. While progress has been made in the treatment of small cell lung cancer better treatment strategies are needed as many patients still experience disease recurrence. Treatment for recurrent non small cell lung cancer japanese journal of clinical oncology. Patients experiencing a recurrence of nsclc historically have had few treatment options.